Dayoung Ko, MD
Dermatology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 6 carriers
- Office
- 1
Offices
1 location · Golden State Dermatology Associates, Inc. · 118 clinicians in this group
Looking this up.
Hospitals listed: Corewell Health Farmington Hills Hospital. That is not proof they admit you there this week.
Plans that list them
24 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ko’s office at (408) 317-3688 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Beaumont Hospital - Farmington HillsFarmington Hills, MIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Corewell Health, which runs 23 hospitalsPatients rate it 2 of 5 · 53% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.344, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.536, Oct 2024 – Sep 2025
See every measure and the patient survey for Beaumont Hospital - Farmington Hills
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.344 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.84) · 808 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.66 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.81 (108.65 to 224.98) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 349 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 322 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,608 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.07 to 0.49) · 5,189 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.45) · 5,234 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.93 (1.71 to 6.14) · 758 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.29) · 204 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.6 to 3.72) · 735 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.1 (0.34 to 17.85) · 190 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.29 (1.28 to 9.31) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 136 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.02 to 1.32) · 4,513 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 37 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.976 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.808 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.655 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 160 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 874 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 31.3 · 90 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.2 · 414 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 41.3 · 336 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 612 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (4.8 to 9.1) · 254 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (8.4 to 13.8) · 254 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 30 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.1 · 296 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.5 to 16.4) · 777 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 337 cases | No different | Jan 2024 – Dec 2024 |
What patients said (712 patients answered, 18% of those asked)
| Cleanliness | 1 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 51% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 55% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 53% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$43,293
Medicare paid this office $43,293 for 176 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of skin growth, 1-14 growths | 53 | $5,925 | $79 |
| Return visit (30+ min) | 50 | $5,752 | $91 |
| Short return visit (20+ min) | 52 | $3,904 | $65 |
| Biopsy of related skin growth, first growth | 46 | $3,319 | $61 |
| New patient visit (45+ min) | 23 | $2,739 | $119 |
See all 12 services
| Destruction of skin growth, 1-14 growths | 53 | $5,925 | $79 |
| Return visit (30+ min) | 50 | $5,752 | $91 |
| Short return visit (20+ min) | 52 | $3,904 | $65 |
| Biopsy of related skin growth, first growth | 46 | $3,319 | $61 |
| New patient visit (45+ min) | 23 | $2,739 | $119 |
| Destruction of precancer skin growth, 1 growth | 47 | $2,163 | $33 |
| New patient visit (30+ min) | 29 | $2,069 | $71 |
| Biopsy of related skin growth, each additional growth | 15 | $1,153 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 35 | $977 | $5 |
| Injection into skin growth, 1-7 growths | 15 | $618 | $33 |
| Short return visit | 12 | $542 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $18 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 11 | More than 64% of doctors who do this |
| Removal of skin lesions | 419 | More than 85% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 99 | More than 76% of doctors who do this |
Who their Medicare patients are
176 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 13% · Women 65% · Also on Medicaid 11% · Health risk score 1.26. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 73% · Coronary heart disease 30% · Diabetes 27% · Chronic kidney disease 22% · Depression 19% · Atrial fibrillation 16% · Heart failure 15% · Cancer 14% · COPD 11% · Stroke 6%.
The office billed $120,929, Medicare allowed $58,760 and paid $43,293; for 812 services of 55 kinds; $18 of it was for drugs given in the office and $43,275 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 176 | 812 | 74 | 1.26 | $120,929 | $43,293 |
| 2023 | 62 | 228 | 73 | 1.10 | $36,885 | $14,372 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Destruction of skin growth, 1-14 growths | 22 | $2,282 | $91 |
| New patient visit (30+ min) | 16 | $1,459 | $91 |
| Biopsy of related skin growth, first growth | 20 | $1,227 | $61 |
| Return visit (30+ min) | 11 | $1,131 | $103 |
| Short return visit (20+ min) | 14 | $1,018 | $68 |
| Destruction of precancer skin growth, 1 growth | 18 | $732 | $35 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $248 | $5 |
Drugs they prescribed that Part D paid
$93,703
Pharmacies billed $93,703 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 518) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
491 generic and 27 brand-name prescriptions · $93,703 in drug cost · 50 antibiotic prescriptions to 31 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 65 | $1,902 | $29 |
| Fluorouracil | 23 | $1,730 | $75 |
| Triamcinolone Acetonide | 97 | $941 | $10 |
| Ketoconazole | 49 | $730 | $15 |
| Clindamycin Phosphate | 26 | $683 | $26 |
See all 11 drugs
| Clobetasol Propionate | 65 | $1,902 | $29 |
| Fluorouracil | 23 | $1,730 | $75 |
| Triamcinolone Acetonide | 97 | $941 | $10 |
| Ketoconazole | 49 | $730 | $15 |
| Clindamycin Phosphate | 26 | $683 | $26 |
| Doxycycline Monohydrate | 22 | $254 | $12 |
| Doxycycline Hyclate | 14 | $181 | $13 |
| Hydrocortisone | 45 | $170 | $4 |
| Mupirocin | 20 | $145 | $7 |
| Minoxidil | 13 | $86 | $7 |
| Prednisone | 15 | $44 | $3 |
Year by year
| 2024 | 518 | 212 | 0% (0) | 5% | $93,703 |
| 2023 | 273 | 109 | 0% (0) | 5% | $78,559 |
| 2022 | 339 | 133 | 0% (0) | 11% | $256,157 |
| 2021 | 274 | 109 | 0% (0) | 14% | $163,538 |
| 2020 | 154 | 72 | 0% (0) | None | $121,663 |
| 2019 | 32 | 19 | 0% (0) | None | $6,498 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Ketoconazole | 48 | $988 | $21 |
| Fluocinonide | 18 | $697 | $39 |
| Clobetasol Propionate | 20 | $633 | $32 |
| Clindamycin Phosphate | 18 | $508 | $28 |
| Triamcinolone Acetonide | 23 | $311 | $14 |
| Hydrocortisone | 40 | $217 | $5 |
2022: 6 drugs
| Clobetasol Propionate | 21 | $1,538 | $73 |
| Clindamycin Phosphate | 25 | $1,063 | $43 |
| Fluocinonide | 19 | $956 | $50 |
| Triamcinolone Acetonide | 53 | $863 | $16 |
| Ketoconazole | 30 | $640 | $21 |
| Hydrocortisone | 38 | $385 | $10 |
2021: 6 drugs
| Clindamycin Phosphate | 30 | $1,282 | $43 |
| Fluocinonide | 15 | $903 | $60 |
| Triamcinolone Acetonide | 38 | $769 | $20 |
| Clobetasol Propionate | 14 | $462 | $33 |
| Ketoconazole | 12 | $272 | $23 |
| Hydrocortisone | 28 | $231 | $8 |
2020: 1 drug
| Triamcinolone Acetonide | 27 | $632 | $23 |
Money from drug and device companies
$2,530 in 2025
| 2025 | 22 | 127 | None | $2,530 |
| 2024 | 17 | 78 | None | $1,707 |
| 2023 | 9 | 16 | None | $484 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $388 | 15 payments
|
| Janssen Biotech | Tremfya | $335 | 27 payments
|
| Galderma Laboratories L.P. | Nemluvio | $289 | 16 payments
|
| Sun Pharmaceutical Industries | Ilumya | $278 | 12 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $246 | 14 payments
|
| Genzyme | Dupixent | $220 | 7 payments
|
See all 125 published payments
| Abbvie | Meals · 2025-12-24 | Skyrizi | $8 |
| Sun Pharmaceutical Industries | Education · 2025-12-24 | None | $80 |
| Abbvie | Meals · 2025-12-22 | Rinvoq | $31 |
| Sun Pharmaceutical Industries | Meals · 2025-12-19 | Ilumya | $22 |
| Sun Pharmaceutical Industries | Meals · 2025-12-19 | Ilumya | $11 |
| Revance Therapeutics | Meals · 2025-12-16 | None | $29 |
| Incyte | Meals · 2025-12-15 | Opzelura | $14 |
| Genzyme | Meals · 2025-12-15 | Dupixent | $34 |
| Genzyme | Meals · 2025-12-10 | Dupixent | $25 |
| Janssen Biotech | Meals · 2025-12-09 | Tremfya | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-12-09 | Dupixent | $19 |
| LEO Pharma | Meals · 2025-12-09 | Anzupgo | $24 |
| Arcutis Biotherapeutics | Meals · 2025-12-04 | Zoryve | $14 |
| Abbvie | Meals · 2025-12-03 | Skyrizi | $15 |
| Pfizer | Meals · 2025-11-19 | Cibinqo | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-11-19 | Ilumya | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-11-19 | Ilumya | $1 |
| Galderma Laboratories L.P. | Meals · 2025-11-18 | Nemluvio | $16 |
| Abbvie | Meals · 2025-11-17 | Rinvoq | $28 |
| Ucb | Meals · 2025-11-06 | Bimzelx | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-11-06 | Ilumya | $33 |
| Abbvie | Meals · 2025-11-05 | Botox | $16 |
| Arcutis Biotherapeutics | Meals · 2025-11-05 | Zoryve | $15 |
| Abbvie | Meals · 2025-11-04 | Skyrizi | $20 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $28 |
| Abbvie | Meals · 2025-10-29 | Skyrizi | $12 |
| Almirall | Meals · 2025-10-28 | Klisyri | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-10-24 | Dupixent | $19 |
| Genzyme | Meals · 2025-10-21 | Dupixent | $47 |
| Incyte | Meals · 2025-10-20 | Opzelura | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-10-20 | Winlevi | $29 |
| Lilly USA | Meals · 2025-10-16 | Taltz | $4 |
| Lilly USA | Meals · 2025-10-16 | Taltz | $8 |
| Abbvie | Meals · 2025-10-15 | Rinvoq | $26 |
| Novartis Pharmaceuticals | Meals · 2025-10-14 | Cosentyx | $16 |
| Lilly USA | Meals · 2025-10-13 | Taltz | $29 |
| Abbvie | Meals · 2025-10-03 | Skyrizi | $9 |
| Organon | Meals · 2025-10-02 | Vtama | $15 |
| Genzyme | Meals · 2025-10-01 | Dupixent | $18 |
| Sun Pharmaceutical Industries | Meals · 2025-09-30 | Ilumya | $30 |
| Sun Pharmaceutical Industries | Meals · 2025-09-29 | Ilumya | $28 |
| Abbvie | Meals · 2025-09-09 | Botox | $12 |
| Galderma Laboratories L.P. | Meals · 2025-08-29 | Nemluvio | $15 |
| Janssen Biotech | Meals · 2025-08-27 | Tremfya | $7 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-26 | Sotyktu | $2 |
| Janssen Biotech | Meals · 2025-08-21 | Tremfya | $9 |
| Janssen Biotech | Meals · 2025-08-21 | Tremfya | $7 |
| Botanix SB | Meals · 2025-08-21 | Sofdra | $19 |
| Galderma Laboratories L.P. | Meals · 2025-08-20 | Nemluvio | $5 |
| Sun Pharmaceutical Industries | Meals · 2025-08-20 | Winlevi | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-14 | Sotyktu | $15 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $14 |
| Galderma Laboratories L.P. | Meals · 2025-08-07 | Aklief | $17 |
| Janssen Biotech | Meals · 2025-08-06 | Tremfya | $18 |
| Abbvie | Meals · 2025-08-01 | Skyrizi | $20 |
| Galderma Laboratories L.P. | Meals · 2025-07-25 | Aklief | $21 |
| Janssen Biotech | Meals · 2025-07-23 | Tremfya | $10 |
| Abbvie | Meals · 2025-07-22 | Botox | $12 |
| Galderma Laboratories L.P. | Meals · 2025-07-22 | Nemluvio | $5 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-17 | Sotyktu | $5 |
| Cipher Pharmaceuticals US | Meals · 2025-07-15 | Natroba | $35 |
| Novartis Pharmaceuticals | Meals · 2025-07-11 | Cosentyx | $20 |
| Mayne Pharma Commercial | Meals · 2025-07-11 | None | $9 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $5 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $3 |
| Pfizer | Meals · 2025-07-09 | Cibinqo | $20 |
| Organogenesis | Meals · 2025-06-26 | Cygnus Dual | $24 |
| Janssen Biotech | Meals · 2025-06-25 | Tremfya | $31 |
| Janssen Biotech | Education · 2025-06-08 | Tremfya | $99 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Sotyktu | $1 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Sotyktu | $0 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Sotyktu | $6 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Sotyktu | $1 |
| Galderma Laboratories L.P. | Meals · 2025-06-05 | Nemluvio | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-06-04 | Libtayo | $16 |
| Pfizer | Meals · 2025-05-20 | Cibinqo | $17 |
| Genzyme | Meals · 2025-05-20 | Dupixent | $70 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-15 | Sotyktu | $6 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-15 | Sotyktu | $1 |
| Janssen Biotech | Meals · 2025-05-14 | Tremfya | $8 |
| Galderma Laboratories L.P. | Meals · 2025-05-07 | Aklief | $7 |
| Galderma Laboratories L.P. | Meals · 2025-05-07 | Nemluvio | $25 |
| Genzyme | Meals · 2025-05-06 | Dupixent | $8 |
| Galderma Laboratories L.P. | Meals · 2025-05-02 | Aklief | $5 |
| Janssen Biotech | Meals · 2025-04-30 | Tremfya | $5 |
| Janssen Biotech | Meals · 2025-04-30 | Tremfya | $1 |
| Genzyme | Meals · 2025-04-30 | Dupixent | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-24 | Sotyktu | $23 |
| Janssen Biotech | Meals · 2025-04-23 | Tremfya | $32 |
| Abbvie | Meals · 2025-04-15 | Botox | $16 |
| Galderma Laboratories L.P. | Meals · 2025-04-14 | Nemluvio | $86 |
| Galderma Laboratories L.P. | Meals · 2025-04-09 | Nemluvio | $17 |
| Novartis Pharmaceuticals | Meals · 2025-04-04 | Cosentyx | $20 |
| Abbvie | Meals · 2025-04-03 | Botox | $135 |
| Sun Pharmaceutical Industries | Meals · 2025-03-26 | Winlevi | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-21 | Sotyktu | $2 |
| Galderma Laboratories L.P. | Meals · 2025-03-21 | Nemluvio | $24 |
| Lilly USA | Meals · 2025-03-19 | Ebglyss | $83 |
| Organon | Meals · 2025-03-14 | Vtama | $5 |
| Biofrontera | Meals · 2025-03-12 | None | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-09 | Sotyktu | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-09 | Sotyktu | $91 |
| Galderma Laboratories L.P. | Meals · 2025-03-06 | Aklief | $16 |
| Janssen Biotech | Meals · 2025-03-05 | Tremfya | $5 |
| Janssen Biotech | Meals · 2025-03-05 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-02-28 | Tremfya | $5 |
| LEO Pharma | Meals · 2025-02-21 | Adbry | $16 |
| Galderma Laboratories L.P. | Meals · 2025-02-20 | Aklief | $9 |
| Organon | Meals · 2025-02-20 | Vtama | $78 |
| Janssen Biotech | Meals · 2025-02-19 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-02-19 | Tremfya | $6 |
| Ucb | Meals · 2025-02-19 | Bimzelx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-02-14 | Cosentyx | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-02-13 | Dupixent | $20 |
| Janssen Biotech | Meals · 2025-02-12 | Tremfya | $6 |
| Sun Pharmaceutical Industries | Meals · 2025-02-12 | Winlevi | $4 |
| Galderma Laboratories L.P. | Meals · 2025-02-01 | Aklief | $2 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-30 | Sotyktu | $80 |
| Janssen Biotech | Meals · 2025-01-29 | Tremfya | $16 |
| Incyte | Meals · 2025-01-23 | Opzelura | $21 |
| Janssen Biotech | Meals · 2025-01-15 | Tremfya | $7 |
| Janssen Biotech | Meals · 2025-01-08 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-01-08 | Tremfya | $6 |
See earlier years (2024, 2023)
2024: $1,707
| Dermavant Sciences | Vtama | $339 | 16 payments
|
| Janssen Biotech | Tremfya | $276 | 14 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $209 | 9 payments
|
| Sun Pharmaceutical Industries | Winlevi | $204 | 9 payments
|
| Arcutis Biotherapeutics | Zoryve | $153 | 5 payments
|
| Amgen | Otezla | $89 | 4 payments
|
| Incyte | Opzelura | $77 | 3 payments
|
| Lilly USA | Olumiant | $64 | 3 payments
|
| Abbvie | Rinvoq | $61 | 3 payments
|
| Pfizer | Eucrisa | $56 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $41 | 2 payments
|
| Biofrontera | Ameluz | $32 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $29 | 1 payment
|
| Kyowa Kirin | Poteligeo | $21 | 1 payment
|
| Galderma Laboratories L.P. | Aklief | $20 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $17 | 1 payment
|
| Organon | Hadlima | $17 | 1 payment
|
2023: $484
| Abbvie | Botox | $165 | 5 payments
|
| Lilly USA | Taltz | $102 | 1 payment
|
| Amgen | Otezla | $53 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $36 | 2 payments
|
| Mayne Pharma Commercial | None | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $30 | 1 payment
|
| Ucb | Cimzia | $28 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $17 | 1 payment
|
| Pfizer | Eucrisa | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1336601822
- Licence
- MI 4301509209
- Trained
- Duke University School of Medicine, 2019
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 43900 Garfield Rd Ste 100, Clinton Township, MI, 48038
- NPI first listed
- 2019-04-03
- NPI last updated
- 2023-12-19
- NPI record certified
- 2023-12-19
This is when the NPI record was last certified, not a medical board exam.